Device
DBS OFF
DBS OFF is a medical device with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Recruiting2
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
unknown125%
recruiting250%
completed125%
Recent Activity
2 active trials
Showing 4 of 4
recruitingnot_applicable
Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children
NCT06529380
recruitingnot_applicable
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
NCT06518824
completednot_applicable
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
NCT03622905
unknownphase_2
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
NCT04938154
Clinical Trials (4)
Showing 4 of 4 trials
NCT06529380Not Applicable
Deep Brain Stimulation for Severe Self-Injurious Behaviour in Children
NCT06518824Not Applicable
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
NCT03622905Not Applicable
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
NCT04938154Phase 2
A Phase 2 Trial of Deep Brain Stimulation for Spasmodic Dysphonia
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4